641 A pilot study of a DNAJB1-PRKACA fusion kinase peptide vaccine combined with nivolumab and ipilimumab for patients with fibrolamellar hepatocellular carcinoma
oleh: Hao Wang, Paul Thomas, Elizabeth M Jaffee, Mark Yarchoan, Jennifer Durham, Brian Ladle, Alex Thompson, Madalena Brancati, Christopher Thoburn, Zeal Kamdar, Marina Baretti, Julie Nauroth, Anna Ferguson, Paige Griffith, Allison Kirk, Neeha Zaidi, Amanda Huff, Won Ho, Mark Furth
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2023-11-01 |
Deskripsi
No description available for this item.